Literature DB >> 12840910

In vitro expression of hepatitis C virus non-structure 5 antigen in the HepG2 cell line.

J Ye1, L Zeng, M Yang, D Luo, J Guo.   

Abstract

To establish a cell line as a model system for HCV infection and propagation in vitro, a human HepG2 cell line was incubated with a HCV RNA positive serum. The sABC immunological techniques and gold-labeled colloid electron microscopy method were employed to examine the viral proteins in those cells. The HCV non-structure 5 antigen was first detected in the HepG2 cells 72 h after incubation. The antigen was continuously observed in the cytoplasm as well on the membrane of the HepG2 cells even after 1, 2, 3 and 4 weeks after incubation. The observation of HCV non-structure 5 antigen continuously expressed in the HepG2 cells strongly indicates that the cells may have been infected by HCV virus. Therefore, the HepG2 cell line may serve as a potential host for establishment of HCV infection and propagation in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12840910     DOI: 10.1007/BF02888178

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  5 in total

1.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

Authors:  R E Lanford; C Sureau; J R Jacob; R White; T R Fuerst
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

3.  The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study.

Authors:  J F Mosnier; C Degott; P Marcellin; D Hénin; S Erlinger; J P Benhamou
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

4.  Persistence of hepatitis C virus RNA in established human hepatocellular carcinoma cell lines.

Authors:  S Tsuboi; S Nagamori; M Miyazaki; K Mihara; K Fukaya; K Teruya; T Kosaka; T Tsuji; M Namba
Journal:  J Med Virol       Date:  1996-02       Impact factor: 2.327

5.  HCV cDNA transfection to HepG2 cells.

Authors:  N Hiramatsu; S Dash; M A Gerber
Journal:  J Viral Hepat       Date:  1997       Impact factor: 3.728

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.